Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

429 public trials 53 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R

NCT05470829

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

NCT05451420

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Henan Provincial People's Hospital Zhengzhou, Henan, China

View Trial Details

Completed

A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis

NCT02499562

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

Beijing, China

View Trial Details

Completed

Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients

NCT03485534

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant

NCT02862548

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Auckland City Hospital Auckland, New Zealand

View Trial Details

Completed

GLS4/RTV and TAF Drug-drug Interaction

NCT04551261

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment

NCT03615066

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: University of Calgary Liver Unit - Heritage Medical Research Clinic Calgary, Alberta, Canada

University Health Network, Toronto General Hospital, Toronto Centre for Liver Disease Toronto, Ontario, Canada

Toronto Liver Centre Toronto, Ontario, Canada

Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum

NCT05355467

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Infection, +15 more
Locations: Taichung Veterans General Hospital Taichung, Taiwan

View Trial Details

Completed

Steatohepatitis in Chronic Hepatitis B

NCT05317260

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +16 more
Locations: Faculty of Medicine Siriraj Hospital Bangkoknoi, Bangkok, Thailand

View Trial Details

Completed

A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

NCT05282407

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Hepatitis B

Hepatitis B trial results

Related conditions